Concepedia

Jeffrey A. Wald

JA

12

Publications

886

Citations

11

H-Index

1975

Active since

Affiliations

University at Buffalo, State University of New York(Current)

GlaxoSmithKline (United States)

Research Triangle Park Foundation

GlaxoSmithKline (United Kingdom)

Jeffrey A. Wald is an author at University at Buffalo, State University of New York specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

1975–2017

12

Publications

12

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 300 citations

Premenstrual Affective Syndrome and Affective Disorder

Richard D. Wetzel, Theodore Reich, James N. McClure et al. · The British Journal of Psychiatry · 1975 · 102 citations

Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release

Robert L. Dobbins, Frank L. Greenway, Lihong Chen et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2015 · 101 citations

Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man

Jeffrey A. Wald, Rebecca M. Law, Elizabeth Ludwig et al. · Journal of Pharmacokinetics and Biopharmaceutics · 1992 · 63 citations

, , +5

An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma

Jeffrey A. Wald, R FARR · Journal of Allergy and Clinical Immunology · 1986 · 63 citations

, , +5

Rows per page

1–5 of 12